X-ray Steps into Europe’s Sterilization Spotlight

Ionisos plans France’s first industrial X-ray site, signaling a shift toward flexible future sterilization options

7 Aug 2025

Europe’s sterilization sector is entering a measured phase of transition as Ionisos begins work on what is set to become France’s first industrial X-ray sterilization site, scheduled to open in 2025. The Henriville project is viewed as an early signal of how operators may expand capacity, improve supply resilience and prepare for tighter regulatory expectations across the region.

Established methods continue to face structural limits. Gamma irradiation depends on a restricted global supply of cobalt-60, while ethylene oxide is subject to increasingly strict environmental rules. These pressures have pushed providers to examine alternative technologies, giving X-ray systems greater visibility. Ionisos’ investment, supported by the European Regional Development Fund, suggests growing confidence in the platform, though the company has not predicted rapid market uptake.

Industry strategists say the shift is driven as much by long-term resilience as by technical innovation. A senior leader at Getinge notes that customers place rising value on reliability and flexibility as device materials and designs change. X-ray systems are seen as complementing existing platforms, a view shared across several manufacturers. Belimed and others have stressed the need for adaptable sterilization options suited to next-generation devices, although few have embarked on projects as prominent as the Henriville site.

The development also fits within a wider effort to diversify sterilization networks in Europe. By adding X-ray capability, Ionisos expands its multi-modality offer and reduces dependence on any single method. Such flexibility is becoming more important as healthcare providers increase their use of polymer-based and minimally invasive devices that require steady and predictable sterilization processes.

Challenges remain substantial. X-ray technology is still newer than legacy methods, and some manufacturers are waiting for more long-term testing data, regulatory validation and clearer economic signals before committing to its use. Infrastructure demands are also significant, with new facilities requiring large capital investment.

Despite these constraints, Ionisos’ project is one of the most notable industrial moves in the sector this year. X-ray could become a core element of Europe’s future sterilization capacity, subject to regulatory acceptance and broader industry adoption.